Gene symbol |
Disease |
Enzyme |
Editing Sites |
Editing Type |
miRBase |
PMID |
Description |
hsa-miR-200b |
|
ADAR1;ADAR2 |
1 |
A-to-I |
MI0000342 |
|
miR-200b editing shows correlations with TP53 in breast cancers. High editing level in miR-200b is associated with worse patient survival. |
hsa-miR-99a |
|
ADAR1;ADAR3 |
1 |
A-to-I |
MI0000101 |
|
miR-99a editing shows correlations with TP53, HRAS, MAP3K1, PIK3CA in breast cancer, head and neck cancer, thyroid cancer. |
has-mir-6503
|
|
ADAR1
|
1 |
A-to-G
|
NA |
|
hsa-miR-6503 are edited within the seed region in a subset of CLL samples but not in B cells. These editing events alter miRNA target specificity and likely affect the pathogenesis of the disease.
|